An economic evaluation of prostate cancer screening using prostate specific antigen in British Columbia
Detecting prostate cancer early in men at risk is of prostate cancer can potentially improve outcomes.
Prostate
National Program on Radioligand Therapy for Prostate Cancer
BACKGROUND: New therapeutics are urgently needed to improve the outcome of men with castrate-resistant prostate cancer (mCRPC), a leading cause of cancer-relat
BC Cancer Foundation is the fundraising partner of BC Cancer, which includes BC Cancer Research. Together with our donors, we are changing cancer outcomes for British Columbians by funding innovative research and personalized treatment and care.